Partners

Our International Network of Partners

Meeting our ambitious goals will not be possible without the committed engagement of our many partners across Alberta, Canada and the World. We are extremely grateful.

map

Medical Institutions

Prostate Cancer Centre (Calgary)

Northern Alberta Urology Centre (Edmonton)

Alberta Health Services (Alberta)

Vancouver Prostate Cancer Centre (Vancouver)

The Prostate Centre at The Princess Margaret Hospital (Toronto)

CHUM Groupe de soutien du cancer de la prostate (Montreal)

London Regional Cancer Program (London, ON)

Technology Platforms

Malvern (UK)

APOGEE (UK)

Nanosight

BGI Genomics (China)

Precision Nanosystems (BC)

Universities

University of Alberta (Edmonton, AB)

University of Calgary (Calgary, AB)

Western University (London, ON)

Dalhousie University (Halifax, NS)

University of Toronto (Toronto, ON)

Vanderbilt University (Nashville, TN)

Case Western Reserve University (Cleveland, OH)

Fraunhofer ITEM-R (Regensburg, Germany)

Biorepositories

Alberta Cancer Research Biobank (Calgary, Edmonton)

Australian Prostate Cancer BioResource (Australia: Melbourne, Sydney, Brisbane and Adelaide)

OICR Tumour Bank (Ontario)

Tomorrow Project 

UHN GU BioBank

Canadian Biosample Repository

Canadian Prostate Cancer Biomarker Network

Financial Resources

Alberta Cancer Foundation (Alberta)

Movember Foundation (Australia, Canada)

Terry Fox Research Institute (Canada)

Motorcycle Ride for Dad (Canada)

Prostate Cancer Canada

Alberta Innovates Health Solutions – Collaborative Research and Innovation opportunities

Alberta Lymphedema Network (Edmonton, Alberta)

University Hospital Foundation – J & J Partnership

Support Groups

Prostate Cancer Canada Network (Canada)

Prostate Cancer Canada Network (Calgary)

Prostate Cancer Canada Network (Edmonton)

New platform for prostate cancer diagnosis to be presented at ISEV 2017

The Lewis Research Group will present exciting results about new blood tests for prostate cancer during 3 talks at the upcoming 2017 International Society of Extracellular Vesicles (ISEV) annual meeting in Toronto (May 18-21). ISEV is a global society of researchers studying exosomes and microvesicles, which are the exciting new focus of cancer therapy and diagnosis.

Dr. Desmond Pink will speak about “Microflow cytometry: The Apogee A50 is a sensitive standard tool for extracellular vesicle analyses in liquid biopsies”, Robert Paproski’s presentation is entitled “Using machine learning of extracellular vesicle flow cytometry to build predictive fingerprints for prostate cancer diagnosis”, and Dr. John Lewis will speak about “An extracellular vesicle blood fingerprint distinguishes between patients with indolent and aggressive prostate cancer at diagnosis”.

The team is looking forward to sharing these key advances that were made possible through the APCaRI prospective cohort.

- John Lewis